Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production.

Autosomal recessive mutations in proteasome subunit β 8 (PSMB8), which encodes the inducible proteasome subunit β5i, cause the immune-dysregulatory disease chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE), which is classified as a proteasome-associated autoinflammatory syndrome (PRAAS). Here, we identified 8 mutations in 4 proteasome genes, PSMA3 (encodes α7), PSMB4 (encodes β7), PSMB9 (encodes β1i), and proteasome maturation protein (POMP), that have not been previously associated with disease and 1 mutation in PSMB8 that has not been previously reported. One patient was compound heterozygous for PSMB4 mutations, 6 patients from 4 families were heterozygous for a missense mutation in 1 inducible proteasome subunit and a mutation in a constitutive proteasome subunit, and 1 patient was heterozygous for a POMP mutation, thus establishing a digenic and autosomal dominant inheritance pattern of PRAAS. Function evaluation revealed that these mutations variably affect transcription, protein expression, protein folding, proteasome assembly, and, ultimately, proteasome activity. Moreover, defects in proteasome formation and function were recapitulated by siRNA-mediated knockdown of the respective subunits in primary fibroblasts from healthy individuals. Patient-isolated hematopoietic and nonhematopoietic cells exhibited a strong IFN gene-expression signature, irrespective of genotype. Additionally, chemical proteasome inhibition or progressive depletion of proteasome subunit gene transcription with siRNA induced transcription of type I IFN genes in healthy control cells. Our results provide further insight into CANDLE genetics and link global proteasome dysfunction to increased type I IFN production.

[1]  E. Krüger,et al.  Dysfunction in protein clearance by the proteasome: impact on autoinflammatory diseases , 2015, Seminars in Immunopathology.

[2]  Yin Liu,et al.  Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. , 2015, Annual review of immunology.

[3]  D. Stetson,et al.  The enemy within: endogenous retroelements and autoimmune disease , 2014, Nature Immunology.

[4]  M. Rustin,et al.  Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature syndrome: a report of a novel mutation and review of the literature , 2014, The British journal of dermatology.

[5]  A. Vanderver,et al.  Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study , 2013, The Lancet Neurology.

[6]  P. Emanuel,et al.  A case of proteasome-associated auto-inflammatory syndrome with compound heterozygous mutations. , 2013, Journal of the American Academy of Dermatology.

[7]  A. Ciechanover Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. , 2013, Bioorganic & medicinal chemistry.

[8]  Ibrahim Osman Adam,et al.  Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination. , 2013, The New England journal of medicine.

[9]  P. Kloetzel,et al.  Immunoproteasomes Are Important for Proteostasis in Immune Responses , 2013, Cell.

[10]  Daniel G. Miller,et al.  Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2 , 2012, Nature Genetics.

[11]  P. Kloetzel,et al.  Emerging roles of immunoproteasomes beyond MHC class I antigen processing , 2012, Cellular and Molecular Life Sciences.

[12]  A. Paller,et al.  Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. , 2012, Arthritis and rheumatism.

[13]  Ricarda Schwab,et al.  Immuno- and Constitutive Proteasome Crystal Structures Reveal Differences in Substrate and Inhibitor Specificity , 2012, Cell.

[14]  P. Kloetzel,et al.  Immunoproteasomes at the interface of innate and adaptive immune responses: two faces of one enzyme. , 2012, Current opinion in immunology.

[15]  D. Standley,et al.  A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans. , 2011, The Journal of clinical investigation.

[16]  P. Kloetzel,et al.  Impairment of Immunoproteasome Function by β5i/LMP7 Subunit Deficiency Results in Severe Enterovirus Myocarditis , 2011, PLoS pathogens.

[17]  N. Niikawa,et al.  Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome , 2011, Proceedings of the National Academy of Sciences.

[18]  A. Garg,et al.  PSMB8 encoding the β5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome. , 2010, American journal of human genetics.

[19]  P. Kloetzel,et al.  Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress , 2010, Cell.

[20]  T. Raivio,et al.  Complex genetics in idiopathic hypogonadotropic hypogonadism. , 2010, Frontiers of hormone research.

[21]  D. Kastner,et al.  Autoinflammatory Disease Reloaded: A Clinical Perspective , 2010, Cell.

[22]  Khalid W. Kalim,et al.  A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis , 2009, Nature Medicine.

[23]  Elke Krüger,et al.  The proteasome maturation protein POMP facilitates major steps of 20S proteasome formation at the endoplasmic reticulum , 2007, EMBO reports.

[24]  A. Goldberg Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy. , 2007, Biochemical Society transactions.

[25]  S. Holland,et al.  Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. , 2006, The New England journal of medicine.

[26]  Torsten Schwede,et al.  The SWISS-MODEL Repository: new features and functionalities , 2005, Nucleic Acids Res..

[27]  P. Kloetzel,et al.  IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Dohmen,et al.  Role of C-terminal Extensions of Subunits β2 and β7 in Assembly and Activity of Eukaryotic Proteasomes* , 2004, Journal of Biological Chemistry.

[29]  M. Konrad,et al.  Salt wasting and deafness resulting from mutations in two chloride channels. , 2004, The New England journal of medicine.

[30]  T. Hayashi,et al.  Central role of defective apoptosis in autoimmunity. , 2003, Journal of molecular endocrinology.

[31]  T. Mizushima,et al.  The structure of the mammalian 20S proteasome at 2.75 A resolution. , 2002, Structure.

[32]  E. Chouery,et al.  An unknown autoinflammatory syndrome associated with short stature and dysmorphic features in a young boy. , 2002, The Journal of rheumatology.

[33]  M. Ferrantini,et al.  IFN‐α2a induces IP‐10/CXCL10 and MIG/CXCL9 production in monocyte‐derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells , 2002, Journal of Leukocyte Biology.

[34]  F. Moreno,et al.  A deletion involving the connexin 30 gene in nonsyndromic hearing impairment. , 2002, The New England journal of medicine.

[35]  Bethan E. Hoskins,et al.  Triallelic Inheritance in Bardet-Biedl Syndrome, a Mendelian Recessive Disorder , 2001, Science.

[36]  M. Kurimoto,et al.  IFN‐α  and IL‐18 synergistically enhance IFN‐γ  production in human NK cells: differential regulation of Stat4 activation and IFN‐γ  gene expression by IFN‐α  and IL‐12 , 2001 .

[37]  K. Melén,et al.  Inflammatory responses in influenza A virus infection. , 2000, Vaccine.

[38]  A. Ballabio,et al.  Double heterozygosity for a RET substitution interfering with splicing and an EDNRB missense mutation in Hirschsprung disease. , 1999, American journal of human genetics.

[39]  L. Kaer,et al.  Immunoproteasome Assembly: Cooperative Incorporation of Interferon γ (IFN-γ)–inducible Subunits , 1998, The Journal of experimental medicine.

[40]  K. Rajewsky,et al.  MHC class I expression in mice lacking the proteasome subunit LMP-7. , 1994, Science.

[41]  T. Dryja,et al.  Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. , 1994, Science.

[42]  K. Tanaka,et al.  Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. , 1994, Journal of biochemistry.

[43]  J. Monaco,et al.  Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene , 1991, Nature.

[44]  S. Beck,et al.  A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC , 1991, Nature.

[45]  J. Monaco,et al.  Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes , 1991, Nature.

[46]  X. Liu,et al.  Digenic inheritance of deafness caused by mutations in genes encoding cadherin 23 and protocadherin 15 in mice and humans. , 2005, Human molecular genetics.